Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 37581 - 37600 out of 496050 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Belgium | (L01EF03) abemaciclib | VERZENIOS 50 mg | 56 filmomhulde tabletten, 50 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ELILILLYBENELUX |
| Belgium | (L01EG02) everolimus (neoplastic diseases) | AFINITOR 10 mg | 30 tabletten, 10 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NOVARTISPHARMA |
| Belgium | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS KRKA 10 mg | 30 tabletten, 10 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | KRKAD.D..(KRKABELGIUM) |
| Belgium | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS SANDOZ 10 mg | 30 tabletten, 10 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SANDOZ |
| Belgium | (L01EG02) everolimus (neoplastic diseases) | AFINITOR 5 mg | 30 tabletten, 5 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NOVARTISPHARMA |
| Belgium | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS KRKA 5 mg | 30 tabletten, 5 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | KRKAD.D..(KRKABELGIUM) |
| Belgium | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS SANDOZ 5 mg | 30 tabletten, 5 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SANDOZ |
| Belgium | (L01EH01) lapatinib | TYVERB 250 mg | 140 filmomhulde tabletten, 250 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NOVARTISPHARMA |
| Belgium | (L01EH03) tucatinib | TUKYSA 150 mg | 84 filmomhulde tabletten, 150 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms; Neoplasm Metastasis | SEAGENBV |
| Belgium | (L01EH03) tucatinib | TUKYSA 50 mg | 88 filmomhulde tabletten, 50 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms; Neoplasm Metastasis | SEAGENBV |
| Belgium | (L01EJ01) ruxolitinib (adm: O) | JAKAVI 10 mg | 56 tabletten, 10 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NOVARTISPHARMA |
| Belgium | (L01EJ01) ruxolitinib (adm: O) | JAKAVI 15 mg | 56 tabletten, 15 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NOVARTISPHARMA |
| Belgium | (L01EJ01) ruxolitinib (adm: O) | JAKAVI 20 mg | 56 tabletten, 20 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NOVARTISPHARMA |
| Belgium | (L01EH01) lapatinib | TYVERB 250 mg | 140 filmomhulde tabletten, 250 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NOVARTISPHARMA |
| Belgium | (L01EJ01) ruxolitinib (adm: O) | JAKAVI 10 mg | 56 tabletten, 10 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NOVARTISPHARMA |
| Belgium | (L01EJ01) ruxolitinib (adm: O) | JAKAVI 20 mg | 56 tabletten, 20 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NOVARTISPHARMA |
| Belgium | (L01EJ01) ruxolitinib (adm: O) | JAKAVI 5 mg | 56 tabletten, 5 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NOVARTISPHARMA |
| Belgium | (L01EJ02) fedratinib | INREBIC 100 mg | 120 capsules, hard, 100 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Primary Myelofibrosis | BRISTOL-MYERSSQUIBBBELGIUM |
| Belgium | (L01EL01) ibrutinib | IMBRUVICA 140 mg | 30 filmomhulde tabletten, 140 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | JANSSEN-CILAG |
| Belgium | (L01EL01) ibrutinib | IMBRUVICA 280 mg | 30 filmomhulde tabletten, 280 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | JANSSEN-CILAG |
Pages
